Literature DB >> 2642916

Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area.

D O Freedman1, T B Nutman, E A Ottesen.   

Abstract

There is little information about naturally occurring protective immunity in individuals living in areas endemic for lymphatic filariasis, though an immunologically hyperresponsive, uninfected group of "endemic normal" individuals that may be immune has been previously recognized. To analyze the nature of the hyperresponsiveness and its potential relation to a state of protective immunity in such individuals, strict clinical, parasitological, and serological criteria were applied to select seven "infection-free" endemic normal individuals (ENs) from a population of 459 persons resident in an area heavily endemic for bancroftian filariasis. Immunoblot analysis was used to compare the qualitative antigen recognition patterns of these endemic normal individuals to those of a group of 12 clearly infected microfilaremic individuals (MFs) from the same endemic area. Though immunoblot analysis using microfilarial and adult stage filarial antigens revealed no distinct differences in antigen recognition patterns between the two groups, when responses to infective larval stage antigens were assessed, 7/7 (100%) of the ENs were found to recognize a 43-kD antigen that was recognized by only 1/12 (8%) of the MFs. These findings are consistent with the concept that recognition of unique larval antigens may induce protective immunity to human filarial parasites and they identify a candidate immunogen for further functional assessment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642916      PMCID: PMC303637          DOI: 10.1172/JCI113850

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Prospects for vaccine against Schistosomiasis.

Authors:  S L James; A Shert
Journal:  Parasitol Today       Date:  1986-05

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The resistance to re-infection of cats repeatedly inoculated with infective larvae of Brugia pahangi.

Authors:  D A Denham; P B McGreevy; R R Suswillo; R Rogers
Journal:  Parasitology       Date:  1983-02       Impact factor: 3.234

4.  Immune responses in human infections with Brugia malayi: correlation of cellular and humoral reactions to microfilarial antigens with clinical status.

Authors:  W F Piessens; P B McGreevy; S Ratiwayanto; M McGreevy; P W Piessens; I Koiman; J S Saroso; D T Dennis
Journal:  Am J Trop Med Hyg       Date:  1980-07       Impact factor: 2.345

5.  Antigenic characterization of adult Wuchereria bancrofti filarial nematodes.

Authors:  T M Morgan; I Sutanto; F Partono; R M Maizels
Journal:  Parasitology       Date:  1986-12       Impact factor: 3.234

6.  Brugia malayi: vaccination of jirds with 60cobalt-attenuated infective stage larvae protects against homologous challenge.

Authors:  J A Yates; G I Higashi
Journal:  Am J Trop Med Hyg       Date:  1985-11       Impact factor: 2.345

7.  Induction of protection against Brugia malayi infection in jirds by microfilarial antigens.

Authors:  J W Kazura; H Cicirello; J W McCall
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

8.  Endemic filariasis on a Pacific Island. II. Immunologic aspects: immunoglobulin, complement, and specific antifilarial IgG, IgM, and IgE antibodies.

Authors:  E A Ottesen; P F Weller; M N Lunde; R Hussain
Journal:  Am J Trop Med Hyg       Date:  1982-09       Impact factor: 2.345

9.  Circulating parasite antigen(s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis.

Authors:  R B Lal; R S Paranjape; D E Briles; T B Nutman; E A Ottesen
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

10.  Successful vaccination of cats against Brugia pahangi with larvae attenuated by irradiation with 10 krad cobalt 60.

Authors:  P Oothuman; D A Denham; P B McGreevy; G S Nelson; R Rogers
Journal:  Parasite Immunol       Date:  1979       Impact factor: 2.280

View more
  18 in total

Review 1.  Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.

Authors:  S J Cryz
Journal:  Experientia       Date:  1991-02-15

2.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

3.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

Review 4.  Insights into the pathogenesis of disease in human lymphatic filariasis.

Authors:  Thomas B Nutman
Journal:  Lymphat Res Biol       Date:  2013-09       Impact factor: 2.589

5.  Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.

Authors:  P T Soboslay; C G Lüder; W H Hoffmann; I Michaelis; G Helling; C Heuschkel; C M Dreweck; C H Blanke; S Pritze; M Banla
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

6.  Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti.

Authors:  N Raghavan; D O Freedman; P C Fitzgerald; T R Unnasch; E A Ottesen; T B Nutman
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Elevated immunoglobulin E against recombinant Brugia malayi gamma-glutamyl transpeptidase in patients with bancroftian filariasis: association with tropical pulmonary eosinophilia or putative immunity.

Authors:  Edgar Lobos; Thomas B Nutman; John S Hothersall; Salvador Moncada
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Host protective immunity and vaccine development studies in lymphatic filariasis.

Authors:  M V Reddy; R Alli; B C Harinath
Journal:  Indian J Clin Biochem       Date:  2000-08

10.  Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis.

Authors:  Anandharaman Veerapathran; Gajalakshmi Dakshinamoorthy; Munirathinam Gnanasekar; Maryada Venkata Rami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.